Drug repositioning and biomarkers in low-grade glioma via bioinformatics approach
Aim: Diffuse low-grade glioma (LGG) patients have a tendency to develop glioblastoma multiforme within 5–10 years, with only 15 months life expectancy. The present study aimed to decode a diagnostic and prognostic gene signature in LGG and identify repositioned potential candidate biomarker therapeu...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2019-01-01
|
| Series: | Informatics in Medicine Unlocked |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352914819302242 |